AGOMAB THERAPEUTICS NV (AGMB) Institutional Shareholders
AGOMAB THERAPEUTICS NV (AGMB) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $336.96M in AGMB holdings during the latest filing period.
Eqt Fund Management S.A R.L. is currently the largest disclosed institutional shareholder of AGMB tracked by InsiderSet, reporting ownership valued at approximately $66.74M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $62.58M, representing an estimated loss of -6.24% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 88% of the total disclosed AGMB value among the investors covered in this analysis. Major shareholders include Eqt Fund Management S.A R.L., Sanofi, Redmile Group, Llc, and several other long-term asset managers with concentrated positions in AGOMAB THERAPEUTICS NV (AGMB).
This page ranks the largest institutional AGMB shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
34
Total Reported Value
$336.96M
Largest Holder
Eqt Fund Management S.A R.L.
Largest Position
$66.74M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
41
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Eqt Fund Management S.A R.L. | 7.74% | 5,141,992 | $66,743,056 | $62,578,043 | -$4,165,013 | -6.24% | |
| Sanofi | 6.76% | 2,783,096 | $36,124,586 | $33,870,278 | -$2,254,308 | -6.24% | |
| Redmile Group, Llc | 2.38% | 2,733,926 | $35,486,359 | $33,271,879 | -$2,214,480 | -6.24% | |
| Cormorant Asset Management, Lp | 1.64% | 2,465,348 | $32,000,217 | $30,003,285 | -$1,996,932 | -6.24% | |
| Tcg Crossover Management, Llc | 0.64% | 2,053,233 | $26,650,964 | $24,987,846 | -$1,663,118 | -6.24% | |
| Federated Hermes, Inc. | 0.03% | 1,618,000 | $21,001,640 | $19,691,060 | -$1,310,580 | -6.24% | |
| Nantahala Capital Management, Llc | 1.23% | 1,568,188 | $20,355,080 | $19,084,848 | -$1,270,232 | -6.24% | |
| Casdin Capital, Llc | 1.01% | 1,550,000 | $20,119,000 | $18,863,500 | -$1,255,500 | -6.24% | |
| Andera Partners | 9.67% | 1,538,702 | $19,972,352 | $18,726,003 | -$1,246,349 | -6.24% | |
| Fmr Llc | 0.00% | 1,458,677 | $18,933,627 | $17,752,099 | -$1,181,528 | -6.24% | |
| Aberdeen Group Plc | 0.02% | 846,695 | $10,990,101 | $10,304,278 | -$685,823 | -6.24% | |
| Perceptive Advisors Llc | 0.12% | 600,000 | $7,788,000 | $7,302,000 | -$486,000 | -6.24% | |
| Samsara Biocapital, Llc | 0.64% | 600,000 | $7,788,000 | $7,302,000 | -$486,000 | -6.24% | |
| Siren, L.L.C. | 0.11% | 411,250 | $5,338,025 | $5,004,913 | -$333,113 | -6.24% | |
| Orbimed Advisors Llc | 0.05% | 192,740 | $2,501,765 | $2,345,646 | -$156,119 | -6.24% | |
| Pfizer Inc | 0.61% | 75,000 | $1,035,750 | $912,750 | -$123,000 | -11.88% | |
| Alps Advisors Inc | 0.00% | 49,984 | $648,792 | $608,305 | -$40,487 | -6.24% | |
| Bellevue Group Ag | 0.01% | 49,248 | $639,239 | $599,348 | -$39,891 | -6.24% | |
| Seven Grand Managers, Llc | 0.02% | 47,600 | $617,848 | $579,292 | -$38,556 | -6.24% | |
| Sectoral Asset Management Inc | 0.39% | 43,500 | $564,630 | $529,395 | -$35,235 | -6.24% | |
| Burkehill Global Management, Lp | 0.02% | 35,000 | $454,300 | $425,950 | -$28,350 | -6.24% | |
| Quadrature Capital Ltd | 0.00% | 20,461 | $265,584 | $249,010 | -$16,574 | -6.24% | |
| Two Sigma Investments, Lp | 0.00% | 18,072 | $234,575 | $219,936 | -$14,639 | -6.24% | |
| Hrt Financial Lp | 0.00% | 17,075 | $221,000 | $207,803 | -$13,197 | -5.97% | |
| Goldman Sachs Group Inc | 0.00% | 11,800 | $153,164 | $143,606 | -$9,558 | -6.24% | |
| Xtx Topco Ltd | 0.00% | 10,271 | $133,318 | $124,998 | -$8,320 | -6.24% | |
| Citigroup Inc | 0.00% | 9,496 | $123,258 | $115,566 | -$7,692 | -6.24% | |
| Ubs Group Ag | 0.00% | 2,128 | $27,622 | $25,898 | -$1,724 | -6.24% | |
| Gamma Investing Llc | 0.00% | 1,344 | $17,445 | $16,356 | -$1,089 | -6.24% | |
| Morgan Stanley | 0.00% | 1,200 | $15,576 | $14,604 | -$972 | -6.24% | |
| Bnp Paribas Financial Markets | 0.00% | 754 | $9,787 | $9,176 | -$611 | -6.24% | |
| Larson Financial Group Llc | 0.00% | 698 | $9,060 | $8,495 | -$565 | -6.24% | |
| Caitong International Asset Management Co., Ltd | 0.00% | 2 | $26 | $24 | -$2 | -6.38% | |
| Sbi Securities Co., Ltd. | 0.00% | 2 | $26 | $24 | -$2 | -6.38% |
Frequently asked questions about AGMB
Who owns the most AGMB stock?
The largest holders of AGMB are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for AGOMAB THERAPEUTICS NV (AGMB).
Is AGMB widely held by superinvestors?
Many widely followed stocks like AGMB appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly AGMB is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.